Sue MacLeman has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development. Sue has also served as CEO and Board member of several ASX and NASDAQ listed companies in the pharmaceutical sector and is currently Chair of Anatara Lifesciences Ltd (ASX:ANR), Chair of Novita Healthcare Ltd (ASX:NHL), Chair and Non-Executive Director of MTPConnect (MTPII-GC Ltd), Non-Executive Director of Oventus Medical Ltd (ASX:OVN) and Non-Executive Director of veski. Sue is also appointed to several academic and government advisory committees. Her broad commercial experience is underpinned by graduate qualifications in pharmacy and post graduate qualifications in commercial law, corporate governance, business administration and marketing
If you would like to update your profile please get in touch.
The COVID-19 Expert Database has been created to provide a mechanism for governments, the business sector, the research sector, and other decision-makers to easily access the expertise they need to inform their decision making.
Australia’s ability to navigate this fast-changing environment and to recover from it needs inputs from a range of researchers and other experts. All fields of expertise including: science, technology, engineering, mathematics, health, humanities, arts, and social science are needed.
If you have expertise that can contribute to the national and global effort to tackle and recover from COVID-19 and its scientific, health, social, cultural and economic implications, please register here.
© 2021 Australian Academy of Science